← Open Payments lookup

MONETTE LALIMAR: Open Payments

NPI 1720147440 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,075 in 146 payments from 25 companies in 2025. Trend: 2023 $4,826 · 2024 $4,121 · 2025 $3,075

Food & beverage: $3,018Education: $57
CompanyPaymentsAmount
ABBVIE INC.26$408
UCB, Inc.15$367
Novartis Pharmaceuticals Corporation14$325
Merz Pharmaceuticals, LLC10$309
Teva Pharmaceuticals USA, Inc.20$212
Amgen Inc.4$179
Eisai Inc.9$159
Biogen, Inc.7$157
Lundbeck LLC8$153
GENZYME CORPORATION2$135

Products named: KESIMPTA, Xeomin, QULIPTA, AUSTEDO XR, Leqembi, Fintepla, VYEPTI, UPLIZNA.

Industry payments across CA — which companies pay providers there.